Tradeview Markets

Three Fed officials backed further rate increases while favoring a gradual approach after this week’s hold. Dallas Fed President Lorie Logan said at least two more 25bp hikes are needed. St. Louis Fed President Alberto Musalem said additional tightening is necessary soon.

Cameco shares fell about 10% after Q3 adjusted net earnings swung to a C$2mn loss from C$32mn a year earlier, while adjusted EBITDA fell 14% to C$267mn. The uranium producer narrowed 2026 output guidance to 19.5-20.5mn lb from 19.5-21.5mn lb.

INOVIO shares jumped 283.5% after hours after the FDA granted accelerated approval to VOCERYQ, its first approved product and the first U.S.-approved plasmid DNA immunotherapy. The treatment is designed to reduce surgeries in adults with recurrent respiratory papillomatosis.

S&P Global revised Meta’s AA- credit outlook to negative from stable, citing uncertainty around AI spending and free operating cash flow. Meta guided to $135bn-$145bn in 2026 capex and reported Q3 free cash flow of -$2.12bn. The AA- rating was affirmed.

U.S. stocks closed sharply lower as renewed scrutiny of AI spending deepened the tech sell-off. The Nasdaq Composite fell 2.9%, the S&P 500 lost 1.8% in its worst session since June, and the Dow dropped 1.1%. Intel slid 28.6%, its steepest decline since 1974.

Kioxia forecast ¥2.0tn in non-GAAP operating profit for the December quarter, below analyst expectations, as NAND price growth slows. Kioxia closed 7.1% lower in Tokyo, while SanDisk fell 13.4% in U.S. trading as investors reassessed memory-pricing momentum.

WEEKLY WRAP | 26–30 OCTOBER 2026 Growth holds. Tech cracks. The Fed held rates steady, U.S. growth stayed firm and inflation remained elevated. Microsoft, Alphabet and Amazon brought the AI debate back to cash flow: cloud demand can grow quickly while infrastructure spending raises the bar for returns. Next up: U.S. midterms, job openings and October payrolls. Watch how earnings, hiring and Treasury yields shape the next move. Swipe through the focus, competing forces and next signals. Save this Weekly Wrap and follow Tradeview Markets for the next update. Updated October 30, 2026. Equity snapshot: 14:15 New York (EDT) / 12:15 Mexico City. Daily changes are intraday observations, not final weekly returns. Friday's final close is not included. Sources: Federal Reserve, BEA, BLS, Amazon, Microsoft, AP and FEC. Full links and verification notes accompany the files. General market commentary for information only. Not investment advice. Trading involves risk. #TradeviewMarkets #WeeklyWrap #MarketUpdate #Earnings #EDGE

Binance said a security breach had an estimated $6.3bn impact, with about $3bn in affected assets frozen. The exchange paused withdrawals, said customer funds remain safe and will cover losses from company funds. Bitcoin fell to a six-week low before stabilizing.

Mexico’s economy grew 0.9% QoQ in Q3, slowing from 1.4% but beating the 0.7% consensus, preliminary INEGI data showed. GDP rose 3.2% YoY versus 2.5% expected. Services grew 1.1%, industry 0.8%, while primary activity fell 0.4%.

Chicago business activity slowed in October, with the PMI falling to 55.3 from 58.8 and missing the 56.1 forecast. The index remained above 50 for a second month, signaling continued expansion despite softer momentum.

U.S. employment costs rose 0.8% in Q3, easing from 0.9% in Q2 and matching forecasts. Over the year, compensation rose 3.4%. Wages and salaries increased 3.1%, while benefit costs climbed 3.9%. Inflation-adjusted wages fell 0.6%.

Round 1: Analyze. Round 2: Execute. Round 3: Profit. 🥊 In the financial markets, you don’t just watch from the corner, you dominate. Follow these 3 steps to land the perfect knockout on your trades. Stay ahead of every round with Tradeview Markets! #TradeviewMarkets #KnockoutTrades #WinEveryRound #TradeToWin #MarketKnockout

AstraZeneca reported Q3 revenue of $16.21bn, up 7% at constant exchange rates, while core EPS rose 19% to $2.79. It launched a restructuring plan targeting $1.5bn in annual pre-tax savings and reconfirmed its 2026 outlook. Shares rose 3%.

ExxonMobil reported Q3 revenue of $113.16bn, up 33% YoY, while adjusted EPS of $4.23 beat the $4.12 consensus. Earnings reached $15.4bn, free cash flow was $19.1bn, and the company set a $20bn 2027 buyback plan. Shares rose 1.3% in morning trade.

Regeneron reported Q3 revenue of $5.12bn, up 36% YoY and above the $4.54bn consensus. Adjusted EPS rose 70% to $20.07 vs. $16.06 expected. Dupixent global sales grew 35% to $6.5bn, while shares rose 4% premarket.

The Bank of Japan held its policy rate at 1.25% in an 8-1 vote. It said underlying inflation is broadly consistent with its 2% target and will accelerate annual ETF sales to ¥860bn from ¥330bn starting in January 2027, while keeping a tightening bias.

AbbVie reported Q3 revenue of $17.40bn, up 10.3% YoY and above the $17.36bn consensus. Adjusted EPS of $3.82 beat the $3.74 estimate. The company raised its 2026 adjusted EPS outlook to $13.95-$13.99 and increased its quarterly dividend by 5.2%.

NatWest reported Q3 operating pretax profit of £2.23bn, up 1.9% YoY and just above the £2.20bn consensus. Net interest income rose 8.9% to £3.56bn but missed estimates, while impairments nearly doubled to £277mn. Shares fell about 6% in London.

MasTec reported record Q3 revenue of $5.15bn, up 29.9% YoY and above the $4.94bn consensus. Adjusted EPS of $2.96 narrowly missed the $2.97 estimate. Its 18-month backlog reached a record $24.5bn, up $7.8bn YoY, while FY2026 adjusted EPS guidance was set at $8.92-$9.30.

BMO closed the sale of its Transportation and Vendor Finance businesses to Stonepeak. At closing, BMO transferred C$11bn, or 75%, of the C$14.5bn portfolio and retained a 19.9% stake. The deal is expected to lift its CET1 ratio by about 23 basis points in fiscal Q4 2026.